144 related articles for article (PubMed ID: 23192646)
1. Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis.
Lee Y; Jeong S; Kim W; Kim H; Yoon JH; Jeong SH; Jung Y
Dig Dis Sci; 2013 May; 58(5):1226-34. PubMed ID: 23192646
[TBL] [Abstract][Full Text] [Related]
2. Sulfate-conjugated methylprednisolone as a colon-targeted methylprednisolone prodrug with improved therapeutic properties against rat colitis.
Kong H; Lee Y; Hong S; Han J; Choi B; Jung Y; Kim YM
J Drug Target; 2009 Jul; 17(6):450-8. PubMed ID: 19527116
[TBL] [Abstract][Full Text] [Related]
3. A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression.
McLeod AD; Fedorak RN; Friend DR; Tozer TN; Cui N
Gastroenterology; 1994 Feb; 106(2):405-13. PubMed ID: 7507873
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.
Kim I; Kong H; Lee Y; Hong S; Han J; Jung S; Jung Y; Kim YM
Pharm Res; 2009 Feb; 26(2):415-21. PubMed ID: 18958401
[TBL] [Abstract][Full Text] [Related]
5. Sulfate-conjugated methylprednisolone: evaluation as a colon-specific methylprednisolone prodrug and comparison with sulfate-conjugated prednisolone and dexamethasone.
Kong H; Kim Y; Lee Y; Choi B; Jung S; Jung Y; Kim YM
J Drug Target; 2009 Feb; 17(2):159-67. PubMed ID: 18988065
[TBL] [Abstract][Full Text] [Related]
6. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression.
Fedorak RN; Haeberlin B; Empey LR; Cui N; Nolen H; Jewell LD; Friend DR
Gastroenterology; 1995 Jun; 108(6):1688-99. PubMed ID: 7768373
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of glucocorticoids to colonic metabolism and pharmacologic intervention in the metabolism: implication for therapeutic activity of colon-specific glucocorticoid 21-sulfate sodium at the target site.
Kong H; Lee Y; Kim H; Hong S; Kim DD; Yoon JH; Jung Y; Kim YM
J Pharm Pharmacol; 2012 Jan; 64(1):128-38. PubMed ID: 22150680
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery.
Kim D; Kim W; Jeong S; Kim D; Yoo JW; Jung Y
Drug Deliv Transl Res; 2019 Feb; 9(1):334-343. PubMed ID: 30426357
[TBL] [Abstract][Full Text] [Related]
9. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
Yang Y; Kim W; Kim D; Jeong S; Yoo JW; Jung Y
Drug Des Devel Ther; 2019; 13():231-242. PubMed ID: 30643389
[TBL] [Abstract][Full Text] [Related]
10. A budesonide prodrug accelerates treatment of colitis in rats.
Cui N; Friend DR; Fedorak RN
Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202
[TBL] [Abstract][Full Text] [Related]
11. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.
Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y
J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354
[TBL] [Abstract][Full Text] [Related]
12. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.
Mehvar R; Hoganson DA
Pharm Res; 2000 Nov; 17(11):1402-7. PubMed ID: 11205734
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
14. N,N'-Bis(5-aminosalicyl)-L-cystine is a potential colon-specific 5-aminosalicylic acid prodrug with dual therapeutic effects in experimental colitis.
Kim H; Huh J; Jeon H; Choi D; Han J; Kim Y; Jung Y
J Pharm Sci; 2009 Jan; 98(1):159-68. PubMed ID: 18399548
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes.
Mehvar R; Dann RO; Hoganson DA
J Control Release; 2000 Jul; 68(1):53-61. PubMed ID: 10884579
[TBL] [Abstract][Full Text] [Related]
16. Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent.
Kim W; Lee Y; Jeong S; Nam J; Lee S; Jung Y
Arch Pharm Res; 2015 Oct; 38(10):1830-8. PubMed ID: 25860026
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Saccharomyces boulardii in a rat model of colitis.
Soyturk M; Saygili SM; Baskin H; Sagol O; Yilmaz O; Saygili F; Akpinar H
World J Gastroenterol; 2012 Nov; 18(44):6452-60; discussion p. 6459. PubMed ID: 23197891
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous analysis of methylprednisolone, methylprednisolone succinate, and endogenous corticosterone in rat plasma.
Mehvar R; Dann RO; Hoganson DA
J Pharm Biomed Anal; 2000 Jul; 22(6):1015-22. PubMed ID: 10857570
[TBL] [Abstract][Full Text] [Related]
19. Alkaline-phosphatase triggered self-assemblies enhances the anti-inflammatory property of methylprednisolone in spinal cord injury.
Yu H; Zhang P; Zhou W; Zhong Z; Qu D
J Appl Biomater Funct Mater; 2020; 18():2280800020978505. PubMed ID: 33535875
[TBL] [Abstract][Full Text] [Related]
20. A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug.
Park S; Kang C; Kim J; Ju S; Yoo JW; Yoon IS; Kim MS; Lee J; Jung Y
Mol Pharm; 2022 Nov; 19(11):3784-3794. PubMed ID: 36043999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
